Results 31 to 40 of about 3,970,076 (263)
Moving from rhetoric to action: how Africa can use scientific evidence to halt the COVID-19 pandemic
The ongoing pandemic of the coronavirus disease 2019 has spread rapidly to all countries of the world. Africa is particularly predisposed to an escalation of the pandemic and its negative impact given its weak economy and health systems.
Olushayo Oluseun Olu +5 more
doaj +1 more source
COVID-19: Lessons from the ‘euro crisis’. EPC Discussion Paper 16 April 2020 [PDF]
The coronavirus is an unprecedented external shock that is challenging the EU and its member states. The crisis is fundamental, posing a dramatic threat to public health and the life of citizens.
Emmanouilidis, Janis A., Zuleeg, Fabian
core
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong +14 more
doaj +1 more source
In this letter, we briefly describe how we selected and implemented the quality criteria checklist (QCC) as a critical appraisal tool in rapid systematic reviews conducted to inform public health advice, guidance and policy during the COVID-19 pandemic ...
Daphne Duval +5 more
doaj +1 more source
Long COVID occurrence in COVID-19 survivors [PDF]
Abstract This cross-sectional study aimed to investigate the post-acute consequences of COVID-19. We conducted a self-administered questionnaire survey on sequelae, psychological distress (K6), impairments in work performance (WFun), and COVID-19–related experiences of stigma and discrimination in two designated COVID-19 hospitals in ...
Aya Sugiyama +14 more
openaire +3 more sources
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, and has spread globally to most countries. In Japan, the first COVID-19 patient was identified on January 15, 2020.
Tokio Hoshina +8 more
doaj +1 more source
Evaluation of self-administered antigen testing in a college setting
Background The objective of our investigation was to better understand barriers to implementation of self-administered antigen screening testing for SARS-CoV-2 at institutions of higher education (IHE).
Sarah C. Tinker +21 more
doaj +1 more source
Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity.
Phillip P. Salvatore +6 more
doaj +1 more source
Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to
Petros Ioannou +9 more
doaj +1 more source
Successful Cessation Programs that Reduce Comorbidity May Explain Surprisingly Low Smoking Rates Among Hospitalized COVID-19 Patients [PDF]
A recent, non-peer-reviewed meta-analysis suggests that smoking may reduce the risk of hospitalization with COVID-19 because the prevalence of smoking among hospitalized COVID-19 is less than that of the general population.
Alvarez, R. Michael +7 more
core

